The prognosis of the aggressive breast cancer depends on demographic characteristics (age, menopause status), tumors (lymphatic ganglionar status, tumor dimension, tumor size, pathogenic type) and biological markers (presence or absence of HER2). Here, ERBB2 is linked to breast carcinoma.